Opus Genetics Inc
Opus Genetics Inc (IRD) Option Chain
As of September 25, 2026, Opus Genetics Inc is trading at $4.76, a -2.26% change from the previous close. The nearest expiration is Oct 16, 2026. Implied volatility is 116.4%. IV Rank is 14%.
Read more
Tracking the IRD option chain helps you see every strike and expiry on Opus Genetics Inc in one view, so you can quickly identify the contracts that fit your thesis and your risk. Opus Genetics Inc's option chain lays out bids, asks, volume, open interest, and Greeks across calls and puts, giving you the full map of IRD options activity at a glance. Use our scanner to monitor the IRD option chain in real time and filter for the IRD options trades that actually meet your criteria.
An option chain is the complete listing of all available option contracts on an underlying, organized by expiration date and strike price. For IRD stock options, the chain shows side-by-side call and put data, making it easy to compare premiums, assess liquidity, and spot pricing dislocations. Reading the IRD option chain effectively means looking beyond the last price — implied volatility by strike, volume-to-open-interest ratios, and bid-ask spreads all tell you where IRD stock options are being actively traded and where they are not.
Opus Genetics, Inc., a clinical-stage ophthalmic biopharmaceutical company, focuses on developing and commercializing therapies for the treatment of unmet needs of patients with refractive and retinal eye disorders. The company offers Phentolamine Ophthalmic Solution for reversal of mydriasis, as well as is in Phase III clinical trials for presbyopia and dim light or night vision disturbances. Its lead retinal product candidate is APX3330, a small-molecule inhibitor of reduction oxidation effector factor-1 protein that has completed Phase II clinical trial for the treatment of diabetic retinopathy.
The company also develops APX2009 and APX2014 that are preclinical product candidates for retina indications. The company was formerly known as Ocuphire Pharma, Inc. Opus Genetics, Inc. was founded in 2018 and is headquartered in Farmington Hills, Michigan.
Credit spreads, long calls, iron condors, calendar trades — every strategy starts with the same raw material: a clean, complete option chain. Our scanner pulls Opus Genetics Inc's full chain across every expiry, highlights the most liquid strikes, and lets you screen IRD options by the metrics that matter, from IV skew to volume surges. Stop scrolling through endless rows of IRD stock options — let the full option chain come to you, pre-filtered and ready to trade.
Stock Statistics
- IndustryBiotechnology
- SectorHealthcare
- IV percentile7.94% Subdued
- Market cap (M$)396
- 52 weeks high-32.67%
- 52 weeks low217.33%
- Analyst recommendationStrong Buy
1.00 - Target price$13.00
173.11% above the current stock price - Dividend—
- Payout ratio—
- Earnings date2026-11-11
- P/E—
- Future P/E—
- EPS (ttm)-1.38
- EPS growth next 5 years29.86%
As of September 25, 2026
| CALLs | PUTs | ||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Prob. OTM % | Open Interest | Volume | Extrinsic Value | Intrinsic Value | Bid | Ask | Strike | Moneyness % | Bid | Ask | Intrinsic Value | Extrinsic Value | Volume | Open Interest | Prob. OTM % |
| 1.42 | 43 | 0 | -0.13 | 2.26 | 0.15 | 4.10 | 2.50 | -47.48 | — | 0.05 | 0.00 | 0.05 | 0 | 36 | 98.58 |
| 62.09 | 2,713 | 9 | 0.60 | 0.00 | 0.30 | 0.90 | 5.00 | +5.04 | 0.20 | 0.90 | 0.24 | 0.31 | 1 | 279 | 37.91 |
| 96.17 | 356 | 100 | 0.25 | 0.00 | — | 0.25 | 7.50 | +57.56 | 0.50 | 5.00 | 2.74 | 0.01 | 0 | 34 | 3.83 |
| 99.75 | 0 | 0 | 0.50 | 0.00 | — | 0.50 | 10.00 | +110.08 | 2.60 | 7.50 | 5.24 | -0.19 | 0 | 2 | 0.25 |
As of September 25, 2026
Scan the full option chain in one place
Browse the full IRD option chain across every strike and expiration, filter by IV, volume, and open interest, and evaluate your trade without switching tools.
Start your 14-day free trial→